The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Johnson Steven Andrew since 2008.
The trader's CIK number is 1389221.
At the time of the last reporting, Johnson Steven Andrew was the VP, Preclinical Deve of Respirerx Pharmaceuticals Inc.. (stock ticker symbol RSPI).
Also see all insider trading activities at Respirerx Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | COR | 0 | $0 | 0 | $0 | 8,750 | $3,281 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-12-15 | COR | Option Ex | 8,750 | .38 | 3,281 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Johnson Steven Andrew (VP, Preclinical Deve of Respirerx Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.